| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 08/25/2011 | US20110206716 Synergistic immunogenic fusion protein-polysaccharide conjugate |
| 08/25/2011 | US20110206712 Tuberculosis rv2386c protein, compositions and uses thereof |
| 08/25/2011 | US20110206702 Compositions and methods for the diagnosis and treatment of tumor |
| 08/25/2011 | US20110206663 Anti-Interferon-Alpha Antibodies |
| 08/25/2011 | US20110206615 Probe reagent for measuring oxidative stress |
| 08/25/2011 | CA2789337A1 Hsa-related compositions and methods of use |
| 08/24/2011 | EP2360176A2 Hybrid and tandem expression of neisserial derived proteins |
| 08/24/2011 | EP2360174A1 HBV core antigen particles with multiple immunogenic components attached via peptide ligands |
| 08/24/2011 | EP2359862A1 Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents |
| 08/24/2011 | EP2359138A1 Immobilization substrate and method for producing the same |
| 08/24/2011 | EP2358874A1 Serine protease derivatives and uses in the prevention or the treatment of blood coagulation disorders |
| 08/24/2011 | EP2358873A1 Hybrid alpha-amylases |
| 08/24/2011 | EP2167529B1 Protein layers and their use in electron microscopy |
| 08/24/2011 | EP1934246B1 Matrix metalloproteinase 11 vaccine |
| 08/24/2011 | EP1545625B1 Flexible vaccine assembly and vaccine delivery platform |
| 08/24/2011 | EP1259544B1 Heterologous polypeptide of the tnf family |
| 08/24/2011 | EP1056868B1 Human homolog of the drosophila protein 'fused' |
| 08/24/2011 | EP0981618B2 Anti-apo-2 antibody |
| 08/24/2011 | CN102164949A Novel nonnatural protein |
| 08/24/2011 | CN102162813A Reagent kit and method for detecting T-2 toxin by using genetically engineered single-chain antibody |
| 08/24/2011 | CN102161998A Deoxyribonucleic acid (DNA) vaccine based on B7-1-PE40KDEL exotoxin fusion gene and application thereof |
| 08/23/2011 | US8003763 for in vitro diagnostics/antitumor agents; gene overexpression of cell surface proteins; bind Cripto and block the interaction between Cripto and activin-like kinase (ALK) 4 |
| 08/23/2011 | US8003757 Receptor-based interaction trap |
| 08/23/2011 | US8003351 Activatable recombinant neurotoxins |
| 08/23/2011 | CA2574929C Bone morphogenetic protein (bmp)-17 and bmp-18 and compositions |
| 08/23/2011 | CA2296807C Erbb4 receptor-specific neuregulin related ligands and uses therefor |
| 08/23/2011 | CA2203888C Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 08/18/2011 | WO2011100292A1 Immunoassay standards and measurement of clinical biomarkers using intra-assay calibration standards |
| 08/18/2011 | WO2011046946A3 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
| 08/18/2011 | WO2011029008A3 Synbodies to akt1 |
| 08/18/2011 | WO2011000962A9 Hiv related peptides combination or fusion for use in hiv vaccine composition or as diagnostic means |
| 08/18/2011 | US20110201560 Peptides for inhibiting the hpv-e6 oncoprotein |
| 08/18/2011 | US20110201112 Vault Complexes for Facilitating Biomolecule Delivery |
| 08/18/2011 | US20110200628 Chimeric Proteins that Induce Effects Directed Against Viruses |
| 08/18/2011 | US20110200622 Polypeptide specifically binding to vascular endothelial growth factor, fusion protein including polypeptide, and methods therefor |
| 08/17/2011 | EP2357238A2 Compositions and methods for regulation of tumor necrosis factor-alpha |
| 08/17/2011 | EP2357187A1 Molecules with extended half-lives, compositions and uses thereof |
| 08/17/2011 | EP2357008A1 Albumin fusion proteins |
| 08/17/2011 | EP2355849A1 Methods of improving the therapeutic efficacy and utility of antibody fragments |
| 08/17/2011 | EP2355842A1 Priming of an immune response |
| 08/17/2011 | CN102154355A Recombinant immunotoxin CCL25-PE38 gene and preparation method as well as application thereof |
| 08/17/2011 | CN102154346A Method for producing human stromal cell derived factor (SDF)-1-Fc in large scale by using mammalian cells |
| 08/17/2011 | CN102154324A Construction method of mycobacterium tuberculosis fusion protein Mtb 10.4-Hsp16.3, expression method thereof, purification method thereof and application thereof |
| 08/17/2011 | CN102153658A Tumor antigen, DC (dendritic cell) tumor vaccine and preparation method thereof |
| 08/17/2011 | CN102153657A IL-24-TAT PTD fusion protein and construction method and application thereof |
| 08/17/2011 | CN102153656A Vaccine for chimeric virus-like particles and preparation method thereof |
| 08/17/2011 | CN102153655A Targeted anti-tumor recombinant protein and preparation method thereof |
| 08/17/2011 | CN102153654A Branched polypeptide using immune active peptide as vector and derivatives and application of branched polypeptide |
| 08/17/2011 | CN102153653A Fusion protein of tumor blood vessel targeted polypeptide and tissue factor and preparation method thereof |
| 08/17/2011 | CN102153652A Expression method and application of fusion protein |
| 08/17/2011 | CN102153644A Antigenic peptide for dimerization of epidermal growth factor receptor |
| 08/17/2011 | CN102153634A Bt binary toxin protein, gene for coding Bt binary toxin protein and application |
| 08/17/2011 | CN102151332A Helicobacter pylori epitope vaccine, design method thereof, preparation method thereof and application thereof |
| 08/16/2011 | CA2354325C Growth factor homolog zvegf3 |
| 08/11/2011 | WO2011097527A2 Immunoprotection of therapeutic moieties using enhanced fc regions |
| 08/11/2011 | WO2011096501A1 Photosensitizing fluorescent protein |
| 08/11/2011 | WO2011095628A1 Fusion proteins comprising antigenic apob-100 protein fragments and a protein carrier, related compositions, methods and systems for treatment and/or prevention of atherosclerosis |
| 08/11/2011 | US20110197291 Endoplasmic Reticulum Localization Signals |
| 08/11/2011 | US20110196128 Murine zcytor17 ligand polynucleotides |
| 08/11/2011 | US20110195902 Fusion Protein Composed of Matrix Metalloproteinase-2 Inhibitor Peptide Derived From Amyloid-B Precursor Protein and Tissue Inhibitor of Metalloproteinase-2 |
| 08/11/2011 | US20110195895 Fgf21 mutants and uses thereof |
| 08/11/2011 | US20110195861 Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit |
| 08/11/2011 | US20110195452 set of sequences for targeting expression and control of the post-translational modification of a recombinant polypeptide |
| 08/11/2011 | US20110195077 Methods and compositions using fgf23 fusion ppolypeptides |
| 08/11/2011 | US20110195067 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCy RECEPTORS |
| 08/11/2011 | CA2789120A1 Fusion proteins comprising antigenic apob-100 protein fragments and a protein carrier, related compositions, methods and systems for treatment and/or prevention of atherosclerosis |
| 08/10/2011 | EP2354791A1 Immunocytokines with modulated selectivity |
| 08/10/2011 | EP2354149A1 Molecules with extended half-lives, compositions and uses thereof |
| 08/10/2011 | EP1212349B1 Recombinant subunit vaccine |
| 08/10/2011 | EP1190074B1 Recombinant anti-cd40 antibody and uses thereof |
| 08/10/2011 | CN102146139A Fusion protein capable of synthetizing trehalose and application thereof in culture of dwarfed lawn grass |
| 08/10/2011 | CN101475644B Novel targeted fusion protein with anti-inflammatory action and use thereof |
| 08/09/2011 | US7994299 Compositions and methods for increasing bone mineralization |
| 08/09/2011 | US7994284 Connective tissue growth factor (CTGF-3) polypeptides |
| 08/09/2011 | US7994283 Dimeric proteins for immunization |
| 08/09/2011 | US7994282 Card proteins involved in cell death regulation |
| 08/09/2011 | US7994117 Thrombopoietic compounds |
| 08/09/2011 | US7993878 Antibodies to human IL-1β |
| 08/09/2011 | US7993845 ACPL-related assays |
| 08/09/2011 | CA2481731C Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/09/2011 | CA2404155C Methods for purifying highly anionic proteins |
| 08/09/2011 | CA2267068C Renilla luciferase and green fluorescent protein fusion genes |
| 08/09/2011 | CA2253240C Hereditary hemochromatosis gene |
| 08/09/2011 | CA2146328C C-c ckr-1, c-c chemokine receptor |
| 08/04/2011 | WO2011094584A2 Method and system for purifying and quantitating proteins using heme fusion tags |
| 08/04/2011 | WO2011094430A2 Pro-angiogenic fragments of prominin-1 and uses thereof |
| 08/04/2011 | WO2011070214A3 Conjugates and compositions for immunotherapy and anti-tumor treatment |
| 08/04/2011 | WO2011038313A3 Selective oxidation of c-h bonds of modified substrates by p450 monooxygenase |
| 08/04/2011 | US20110191873 Methods of Protein Destabilization and Uses Thereof |
| 08/04/2011 | US20110190216 Materials and methods for treatment of spinal muscular atrophy and taxane-induced peripheral neuropathy (tipn) |
| 08/04/2011 | US20110190196 Improved peptide mediators of cholesterol efflux |
| 08/04/2011 | US20110190164 Chimeric fusion proteins and virus like particles from birnavirus vp2 |
| 08/04/2011 | US20110190144 Novel compositions and methods for the treatment of psoriasis |
| 08/04/2011 | US20110189752 Complex |
| 08/04/2011 | US20110189751 Methods and compositions comprising heat shock proteins |
| 08/04/2011 | US20110189284 Peptide Fibres |
| 08/04/2011 | US20110189268 Inhibition of Placenta Growth Factor (PLGF) Mediated Metastasis and/or Angiogenesis |
| 08/04/2011 | US20110189263 Peptides that target dorsal root ganglion neurons |
| 08/04/2011 | US20110189218 Plasmodium vivax hybrid circumsporozoite protein and vaccine |
| 08/04/2011 | US20110189209 Fold-back diabody diphtheria toxin immunotoxin and methods of use |